Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Spero Therapeutics Inc banner

Spero Therapeutics Inc
F:2HA

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
F:2HA
Watchlist
Price: 0.9065 EUR -4.07% Market Closed
Market Cap: €1.5m
Write Note Create Alert

Intrinsic Value

2HA price has not been updated for more than 7 years. This may indicate that the stock has been delisted.

Is 2HA undervalued or overvalued?

See the intrinsic value estimate for Spero Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

2HA Intrinsic Value
LOCKED
Unlock
Today vs. history

2HA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with 2HA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 2HA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €0.91
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 2HA

Fundamental Analysis

What Spero Therapeutics Does

Biotechnology Health Care

Spero Therapeutics is a biotechnology company that develops medicines for hard-to-treat bacterial infections, with a focus on infections caused by drug-resistant Gram-negative bacteria. Its work centers on antibiotic candidates designed to be taken by mouth or given in other convenient ways, so they can treat serious infections that often require hospital care.

Headquarters
United States of America US
Employees
25
IPO date
Nov 2, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Spero Therapeutics Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

SPRO Insider Trading
Buy and sell transactions by insiders

Continue 2HA Research

Summary
2HA intrinsic value, competitors valuation, and company profile.
DCF Valuation
2HA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2HA stock valuation using valuation multiples.
Wall St Estimates
2HA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2HA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Spero Therapeutics Inc listings:
NASDAQ • USD
SPRO
 SWB • EUR
2HA
Discover More
What is the Intrinsic Value of one 2HA stock?

The intrinsic value for Spero Therapeutics Inc (2HA) under the Base Case is hidden EUR.

Is 2HA stock undervalued or overvalued?

Compared with the current market price of 0.9065 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.